H79TI085774
Project Grant
Overview
Grant Description
State Opioid Response Grants - Nebraska
The purpose of the Nebraska State Opioid Response (SOR) program is to increase access to FDA-approved medications for the treatment of Opioid Use Disorder (OUD) and support prevention, risk reduction, treatment, and recovery services for OUD and other concurrent Substance Use Disorders (SUD) including stimulant use and misuse.
The Nebraska SOR program achieves this through our ongoing collaboration with healthcare and community-based service providers, subject matter experts, stakeholders, and key leaders across the care continuum. Additionally, the SOR program aims to mitigate the effects of OUD and SUDs, including the use and misuse of stimulants, prescription opioids, and illicit drugs.
This is done by identifying needs, increasing access to treatment including Medication-Assisted Treatment (MAT) and naloxone, providing OUD and stimulant education, and reducing drug overdose and stimulant deaths through the provision of prevention, risk reduction, treatment, and recovery activities.
The Division of Behavioral Health (DBH) intends to partner with agencies and key community sectors to provide services to underserved and at-risk populations living in both rural and urban communities statewide. The SOR intends to assess needs, provide opioid and stimulant education and awareness, and reduce stigma surrounding OUD, stimulant use and misuse, and concurrent SUDs.
FDA-approved MAT medications will be provided in addition to the distribution of naloxone to communities of need, at-risk individuals, first responders, and others. Nebraska's focus on treatment includes implementing clinically appropriate Evidence-Based Practices (EBPs) for OUD and stimulant use treatment, including training providers in the ECHO model. It also involves enhancing the utilization of MAT through the funding of buprenorphine, providing training and education to peer support specialists on opioids and stimulants, and assisting patients with treatment and recovery costs.
SOR funding will also assist in providing recovery-oriented care through supportive housing and trauma-informed care. DBH will work with community coalitions and regional behavioral health authorities to implement EBPs targeting Nebraska school-aged children.
Over the anticipated two-year time period of the SOR grant, DBH intends to reach approximately 230 individuals with treatment services, 550 recovery support services, and 1,000,000 through targeted prevention activities.
The purpose of the Nebraska State Opioid Response (SOR) program is to increase access to FDA-approved medications for the treatment of Opioid Use Disorder (OUD) and support prevention, risk reduction, treatment, and recovery services for OUD and other concurrent Substance Use Disorders (SUD) including stimulant use and misuse.
The Nebraska SOR program achieves this through our ongoing collaboration with healthcare and community-based service providers, subject matter experts, stakeholders, and key leaders across the care continuum. Additionally, the SOR program aims to mitigate the effects of OUD and SUDs, including the use and misuse of stimulants, prescription opioids, and illicit drugs.
This is done by identifying needs, increasing access to treatment including Medication-Assisted Treatment (MAT) and naloxone, providing OUD and stimulant education, and reducing drug overdose and stimulant deaths through the provision of prevention, risk reduction, treatment, and recovery activities.
The Division of Behavioral Health (DBH) intends to partner with agencies and key community sectors to provide services to underserved and at-risk populations living in both rural and urban communities statewide. The SOR intends to assess needs, provide opioid and stimulant education and awareness, and reduce stigma surrounding OUD, stimulant use and misuse, and concurrent SUDs.
FDA-approved MAT medications will be provided in addition to the distribution of naloxone to communities of need, at-risk individuals, first responders, and others. Nebraska's focus on treatment includes implementing clinically appropriate Evidence-Based Practices (EBPs) for OUD and stimulant use treatment, including training providers in the ECHO model. It also involves enhancing the utilization of MAT through the funding of buprenorphine, providing training and education to peer support specialists on opioids and stimulants, and assisting patients with treatment and recovery costs.
SOR funding will also assist in providing recovery-oriented care through supportive housing and trauma-informed care. DBH will work with community coalitions and regional behavioral health authorities to implement EBPs targeting Nebraska school-aged children.
Over the anticipated two-year time period of the SOR grant, DBH intends to reach approximately 230 individuals with treatment services, 550 recovery support services, and 1,000,000 through targeted prevention activities.
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Nebraska
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 19% from $4,492,812 to $5,360,421.
Nebraska Department Of Health And Human Services was awarded
Nebraska SOR Grants: Opioid Treatment & Recovery
Project Grant H79TI085774
worth $5,360,421
from the Division of Grants Management in September 2022 with work to be completed primarily in Nebraska United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Complete)
Last Modified 6/5/25
Period of Performance
9/30/22
Start Date
9/29/24
End Date
Funding Split
$5.4M
Federal Obligation
$0.0
Non-Federal Obligation
$5.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for H79TI085774
Transaction History
Modifications to H79TI085774
Additional Detail
Award ID FAIN
H79TI085774
SAI Number
H79TI085774-1570205841
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA Division of Grants Management
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
HKQDEXRXGKL1
Awardee CAGE
3UDU3
Performance District
NE-90
Senators
Deb Fischer
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Substance Abuse Treatment, Substance Abuse and Mental Health Administration, Health and Human Services (075-1364) | Health care services | Grants, subsidies, and contributions (41.0) | $9,142,547 | 100% |
Modified: 6/5/25